Results 131 to 140 of about 75,538 (267)

Exposure to environmental toxicants and obstructive sleep apnea: a cross-sectional study. [PDF]

Future Sci OA
Liu W, Li P, Wang Z, Liu Y, Chen J, Liu H, Yang Q, Ye J.   +7 more
europepmc   +1 more source

Wernicke's Encephalopathy Following Semaglutide Treatment for Obesity: A Systematic PRISMA Review of Case‐Based Evidence

Obesity, EarlyView.
ABSTRACT Objective Glucagon‐like peptide‐1 receptor agonists are increasingly prescribed for obesity. Although generally considered safe, marked appetite suppression and persistent gastrointestinal adverse effects may increase the risk of nutritional deficiencies.
Janice Bidesie, Erik Oudman
wiley   +1 more source

Trends in Diagnosing Obesity: The CALOR Study

Obesity, EarlyView.
Data from the CALOR study suggest that in people with elevated BMI in the US and Japan, there is underdiagnosis of obesity and a high prevalence of diseases interrelated to obesity. ABSTRACT Objective This study aimed to describe characteristics of people with elevated BMI by presence versus absence of obesity diagnosis and trends over time.
Deborah B. Horn, Eva Lesén, Christen M. Gray, Magnus Bjursell, Hironori Waki   +4 more
wiley   +1 more source

Obstructive sleep apnea is linked to inflammatory changes and motor impairment in Parkinson's disease. [PDF]

Front Immunol
de Almeida CMO, do Valle-Filho MF, Costa Said R, Dantas JM, Azedo AL, Ferreira MC, Noronha E, Perez YG, Sobreira-Neto MA, Lopes ALRB, Coletta MVD, Carvalho NO, Teixeira-Carvalho A, Carvalho DM, Pontes GS.   +14 more
europepmc   +1 more source

PREDICT‐PD: A Two‐Stage Approach to Early Identification of Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Sasivimol Virameteekul, Sheena Waters, Brook Huxford, Ashvin Kuri, Manuela Tan, Laura Pérez‐Carbonell, Eduardo de Pablo‐Fernández, Anette Schrag, Alastair J. Noyce, Cristina Simonet   +9 more
wiley   +1 more source

Oral GLP‐1RA TERN‐601 for Adults With Obesity/Overweight: Placebo‐Controlled, Multiple‐Ascending‐Dose, Phase 1 and 2 Studies

Obesity, EarlyView.
ABSTRACT Objective The safety, tolerability, pharmacokinetics, and efficacy of TERN‐601, a once‐daily, oral small‐molecule glucagon‐like peptide‐1 (GLP‐1) receptor agonist, were studied in Phase 1 and 2 clinical studies. Methods The Phase 1 (28‐day) and Phase 2 (12‐week), randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose studies ...
W. Timothy Garvey, Julio Rosenstock, Harold E. Bays, Douglas Denham, Anita Kohli, Melanie Haines, Christopher Jones, Ellen Kwan, Erin Castelloe, Tonya Marmon, Emil Kuriakose, Cara Nelson   +11 more
wiley   +1 more source

Heterogeneity of vascular inflammation in obstructive sleep apnea: effects of continuous positive airway pressure therapy. [PDF]

Ann Am Thorac Soc
Kundel V, Gans A, Lee JH, Cohen O, Khan S, Le V, Patel H, McAlpine CS, Fayad ZA, Robson PM, Mani V, Suárez-Fariñas M, Shah NA.   +12 more
europepmc   +1 more source

Obstructive Sleep Apnea and Stroke [PDF]

Journal of Clinical Sleep Medicine, 2018
Anupama, Gupta, Garima, Shukla
openaire   +2 more sources

Nonpharmacologic Therapy for Pediatric Posttonsillectomy Pain: A Systematic Review

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To understand efficacies of nonpharmacologic therapy for pediatric posttonsillectomy pain. Data Sources CINAHL, Cochrane Library, PubMed, and Scopus. Review Methods Studies on nonpharmacologic interventions for pediatric posttonsillectomy pain were included in this systematic review.
Justina T. Sargios, David Kayekjian, Shaun A. Nguyen, Pete Peters, Clarice S. Clemmens, William W. Carroll   +5 more
wiley   +1 more source

Obstructive sleep apnea and dementia: the case for greater phenotypic precision. [PDF]

Sleep
Yiallourou S, Pase MP.
europepmc   +1 more source